| Title: | Albumin and multiple sclerosis: a prospective study from UK Biobank |
| Journal: | Frontiers in Immunology |
| Published: | 10 Jun 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38915402/ |
| DOI: | https://doi.org/10.3389/fimmu.2024.1415160 |
| URL: | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1415160/pdf |
Publication 11887
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system. While previous studies have indicated that albumin, the primary protein in human plasma, may exert influence on the inflammatory process and confer beneficial effects in neurodegenerative disorders, its role in the context of MS has been underexplored. Here, we aimed to explore the link between albumin and the risk of MS.</p>
Methods: Employing data from the UK Biobank, we investigated the association between baseline levels of serum and urine albumin and the risk of MS using Cox proportional hazards regression analysis.</p>
Results: A higher baseline level of serum albumin was associated with a lower risk of incident MS (HR=0.94, 95% CI: 0.91-0.98, P=7.66E-04). Subgroup analysis revealed a more pronounced effect in females, as well as participants with younger ages, less smoking and deficient levels of vitamin D. Conversely, no association was identified between baseline microalbuminuria level and risk of incident MS.</p>
Conclusion: Higher serum albumin level at baseline is linked to a reduced risk of MS. These results contribute to an enhanced understanding of albumin's role in MS, propose the potential use of albumin as a biomarker for MS, and have implications for the design of therapeutic interventions targeting albumin in clinical trials.</p>
15 Keywords
- Adult
- Aged
- Albuminuria
- Biological Specimen Banks
- Biomarkers
- Female
- Humans
- Male
- Middle Aged
- Multiple Sclerosis
- Prospective Studies
- Risk Factors
- Serum Albumin
- UK Biobank
- United Kingdom
4 Authors
- Ke Chen
- Chunyu Li
- Bi Zhao
- Huifang Shang
1 Application
| Application ID | Title |
|---|---|
| 98992 | Precision medicine of central nervous system diseases combining demographics, imaging, genetics, and other omics |
Enabling scientific discoveries that improve human health